Clinical trial
A Randomized Controlled Trial of Intra-arterial Reperfusion Therapy After Standard Dose Intravenous t-PA Within 4.5 Hours of Stroke Onset Utilizing Dual Target Imaging Selection.
NCT01492725 is registered in ClinicalTrials.gov with Neuroscience Trials Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Intra-arterial Reperfusion Therapy After Standard Dose Intravenous t-PA Within 4.5 Hours of Stroke Onset Utilizing Dual Target Imaging Selection.
- Lead sponsor
- Neuroscience Trials Australia
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- June 30, 2012
- Completion date
- December 31, 2014
- Enrollment
- 70 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.